Guilford, Pfizer deal

PFE received exclusive worldwide rights to a class of n-acetylated-alpha-linked-acidic-dipeptidase ( NAALADase) inhibitors from GLFD to treat neurodegenerative diseases. Under the deal, PFE will be re...